AbCellera Biologics Inc vs American Express Co — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while American Express Co trades at $340.05 (market cap $230.15B). The key difference: American Express Co is far larger — about 77× AbCellera Biologics Inc's market cap, and American Express Co pays a 1.11% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AXP | |
|---|---|---|
Market Cap | $2.99B | $230.15B |
Sector | Health | Financials |
52-Week High | $9.76 | $384.82 |
52-Week Low | $2.78 | $292.27 |
Enterprise Value | $2.58B | — |
Dividend Yield | — | 1.11% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →American Express Company is a global payment and travel company. The Company's principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses around the world.
Read more on AXP →